|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400087388 |
|
最近更新日期: Date of Last Refreshed on: |
2024-07-26 10:08:25 |
|
注册时间: Date of Registration: |
2024-07-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
优化推拿法治疗腰椎间盘突出症的临床疗效评价 |
|
Public title: |
Clinical efficacy evaluation of optimizing tuina therapy for the treatment of lumbar disc herniation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
邵氏思想在腰椎间盘突出症推拿治疗标准化方案中的应用与评价 |
|
Scientific title: |
Application and evaluation of Shao's philosophy in standardized tuina therapy for lumbar disc herniation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
桑佳佳 |
研究负责人: |
桑佳佳 |
|
Applicant: |
Sang Jiajia |
Study leader: |
Sang Jiajia |
|
申请注册联系人电话: Applicant telephone: |
+86 150 0515 6701 |
研究负责人电话:
Study leader's |
+86 150 0515 6701 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
sangtcm@163.com |
研究负责人电子邮件: Study leader's E-mail: |
sangtcm@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省南京市秦淮区汉中路155号 |
研究负责人通讯地址: |
江苏省南京市秦淮区汉中路155号 |
|
Applicant address: |
No.155 Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province |
Study leader's address: |
No.155 Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南京中医药大学附属医院 |
||
|
Applicant's institution: |
Affiliated Hospital of Nanjing University of Chinese Medicine |
||
|
研究负责人所在单位: |
南京中医药大学附属医院 |
||
|
Affiliation of the Leader: |
Affiliated Hospital of Nanjing University of Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024NL-048-02 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京中医药大学附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee, Affiliated Hospital of Nanjing University of Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-09 00:00:00 | ||
|
伦理委员会联系人: |
王卯 |
||
|
Contact Name of the ethic committee: |
Wang Mao |
||
|
伦理委员会联系地址: |
江苏省南京市秦淮区汉中路155号 |
||
|
Contact Address of the ethic committee: |
No.155 Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 135 0514 1991 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南京中医药大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Hospital of Nanjing University of Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市秦淮区汉中路155号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.155 Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
南京中医药大学附属医院资助 |
||||||||||||||||||||||
|
Source(s) of funding: |
Supported by Nanjing University of Traditional Chinese Medicine Affiliated Hospital |
||||||||||||||||||||||
|
研究疾病: |
腰椎间盘突出症 |
||||||||||||||||||||||
|
Target disease: |
Lumbar disc herniation |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
以邵铭熙教授治疗腰突症“筋骨同治”的学术思想与“骨盆牵正技术”为依据,优化推拿治疗方案并加以疗效观察,形成区域内腰突症推拿治疗标准化方案;结合“中医DRG分组与临床应用”的要求,分析腰突症患者住院诊疗费用,明确优化后治疗方案的卫生经济学价值与优势。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on Professor Shao Mingxi's academic philosophy of treating lumbar protrusion with "joint treatment of muscles and bones" and the "pelvic traction technique", optimize the tuina treatment plan and observe its efficacy, forming a standardized tuina treatment plan for lumbar protrusion in the region;Based on the requirements of "grouping and clinical application of traditional Chinese medicine DRG", analyze the hospitalization and treatment costs of patients with lumbar protrusion, and clarify the health economic value and advantages of the optimized treatment plan. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
同时符合LDH中西医诊断标准; 年龄>=18周岁和<=70周岁,病程<=3年; 以单侧腰腿部不适为主,未经手术治疗; 知情同意,志愿受试。 获得知情同意书过程应符合GCP规定。 |
||||||||||||||||||||||
|
Inclusion criteria |
Simultaneously meeting the diagnostic criteria of LDH in both traditional Chinese and Western medicine; Age >=18 years and <= 70 years, disease duration <= 3 years; Mainly characterized by discomfort in one side of the waist and legs, without surgical treatment; Informed consent, voluntary testing. The process of obtaining informed consent should comply with GCP regulations. |
||||||||||||||||||||||
|
排除标准: |
合并心、脑、肝、肾和造血系统等严重原发性疾病患者; 滥用精神类药物患者及精神障碍患者; 合并有其他原因所致腰椎管狭窄者; 出现单根神经麻痹或马尾神经麻痹,表现为肌肉瘫痪或出现直肠、膀胱症状者; 根据研究者的判断、具有降低入组可能性或使入组复杂化的其他病变,如工作环境经常变动等易造成失访的情况; 正在参加其他临床试验的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Patients with severe primary diseases including heart, brain, liver, kidney, and hematopoietic system; Patients who abuse psychotropic drugs and those with mental disorders; Patients with lumbar spinal stenosis caused by other reasons; Individuals with single nerve paralysis or cauda equina paralysis, manifested as muscle paralysis or rectal or bladder symptoms; According to the researcher's judgment, other lesions that may reduce the likelihood of inclusion or complicate inclusion, such as frequent changes in the work environment, are prone to loss to follow-up; Patients currently participating in other clinical trials. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-08-01 00:00:00至 To 2025-08-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-08-01 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
选取110例受试患者,顺序编号、随机数表法分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Select 110 test patients and group them using sequential numbering and random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病历记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |